ONO-7436 Phase II Study in Japan

• Status: Completed
• Trial end date: 1969-12-31

Summary

The purpose of this study is to examine the efficacy and safety of ONO-7436 for the prevention of cancer chemotherapy-induced nausea and vomiting in patients with malignant tumor

• Phase: Phase 2

Details

• Lead Sponsor: Ono Pharmaceutical Co. Ltd
• Treatments: Aprepitant; Fosaprepitant